Evidence map›Paper›PMID 36307788›Full record

ArticleBMC medical genomics2022

Case-control study on CYP4B1 gene polymorphism and susceptibility to gastric cancer in the chinese Han population.

Shuyong Yu, Zhuang Chen, Jiajia Cheng, Xingang Shi, Jiaqi Liu, Ping Zhong, Jian Song

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Spotlight on CYP4B1.International journal of molecular sciences · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shuyong Yu *Department of Gastrointestinal Surgery, Hainan Cancer Hospital, #9, Changbinxisi Street, Xiuying District, Haikou City, Hainan Province, China.
Zhuang Chen *Department of Gastroenterology, Hainan Cancer Hospital, #9, Changbinxisi Street, Xiuying District, Haikou City, Hainan Province, China.
Jiajia Cheng *Department of Gastrointestinal Surgery, Hainan Cancer Hospital, #9, Changbinxisi Street, Xiuying District, Haikou City, Hainan Province, China.
Xingang ShiDepartment of Gastroenterology, Changhai Hospital, Haikou City, China.
Jiaqi LiuDepartment of Gastroenterology, Hainan Cancer Hospital, #9, Changbinxisi Street, Xiuying District, Haikou City, Hainan Province, China.
Ping ZhongDepartment of Gastroenterology, Hainan Cancer Hospital, #9, Changbinxisi Street, Xiuying District, Haikou City, Hainan Province, China.
Jian SongDepartment of Gastroenterology, Hainan Cancer Hospital, #9, Changbinxisi Street, Xiuying District, Haikou City, Hainan Province, China. songjian0532@sina.com.
Hainan Medical College Hospital · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn China, gastric cancer (GC) is one of the most common malignant tumors. This study aimed to explore the relationship of rs2297810, rs4646491 and rs2297809 polymorphisms of CYP4B1 with susceptibility to GC in the Chinese Han population.

methodsA case-control study including 707 GC cases and 707 normal controls was conducted. Three single nucleotide polymorphisms (SNPs) were genotyped by Agena MassARRAY system. Logistic regression analysis was utilized to assess the effects of SNPs on GC risk. Furthermore, multifactor dimensionality reduction (MDR) approach was used to analyze the SNP-SNP interactions.

resultsNo significant relationships were found between rs2297810 and rs2297809 and GC risk under all genetic models. For rs4646491, people with TC genotype had a 1.40-fold higher risk of GC than those with CC genotype (OR = 1.40; 95% CI = 1.13-1.74; p = 0.002), and people with TT-TC genotype had a 1.30-fold higher risk of GC than those with CC genotype (OR = 1.30; 95% CI = 1.06-1.61; p = 0.014). Stratification results showed that GC risk in people carrying TC genotype was higher than that in people with CC genotype, males (OR = 1.36; 95% CI = 1.06-1.75; p = 0.015), non-smokers (OR = 1.52; 95% CI = 1.11-2.07; p = 0.009) and non-drinkers (OR = 1.50; 95% CI = 1.10-2.04; p = 0.010). Additionally, the study also revealed that GC risk in people carrying TT-TC genotype was higher than that in people with CC genotype, males (OR = 1.29; 95% CI = 1.01-1.64; p = 0.040), non-smokers (OR = 1.40; 95% CI = 1.04-1.89; p = 0.027) and non-drinkers (OR = 1.39; 95% CI = 1.03-1.87; p = 0.030).

conclusionThis study firstly found that CYP4B1-rs4646491 was significantly correlated with GC risk, and it might be a risk factor for GC.

Indexed as

Stomach NeoplasmsAryl Hydrocarbon HydroxylasesCase-Control StudiesChinaGenetic Predisposition to DiseaseGenotypeHumansMalePolymorphism, Single NucleotideRisk FactorsAryl Hydrocarbon Hydroxylasescytochrome P-450 CYP4B1AssociationCYP4B1 geneGastric cancerRs4646491Single nucleotide polymorphism

Identifiers

PMID36307788
PMCPMC9615408
OpenAlexW4307711142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.